[Insightec in Business Wire] Breakthrough in treating Alzheimer’s using targeted drug delivery reported in New England Journal of Medicine
MORGANTOWN, W. Va.–(BUSINESS WIRE)–A potential advancement in the treatment of Alzheimer’s disease was announced today by researchers at the West Virginia University Rockefeller Neuroscience Institute (RNI). A first in-human study, featured in the latest issue of the New England Journal of Medicine, demonstrates that focused ultrasound in combination with anti-amyloid-beta monoclonal antibody treatment can accelerate the clearance of amyloid-beta plaques in the brains of patients with Alzheimer’s disease. Read...
Read More